Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey
S Liu, J Liu, L Si, X Ke, L Liu, Y Ren, S Bao, F Li… - BMJ Global …, 2023 - gh.bmj.com
Objective This study aimed to investigate the preferences regarding risks, benefits and other
treatment attributes of patients with type 2 diabetes mellitus (T2DM) in China when selecting …
treatment attributes of patients with type 2 diabetes mellitus (T2DM) in China when selecting …
What is valued most by patients with type 2 diabetes mellitus when selecting second-line antihyperglycemic medications in china
Objective: To estimate patient preferences for second-line antihyperglycemic medications in
China. Methods: A face to face survey with the best-worst scaling (BWS) choices was …
China. Methods: A face to face survey with the best-worst scaling (BWS) choices was …
[HTML][HTML] Capturing adult patient preferences toward benefits and risks of second-line antihyperglycemic medications used in type 2 diabetes: a discrete choice …
Objectives To estimate the strength of preferences, relative importance and trade-offs that
patients with type 2 diabetes make between characteristics of antihyperglycemic …
patients with type 2 diabetes make between characteristics of antihyperglycemic …
Patient preferences for attributes of type 2 diabetes mellitus medications in Germany and Spain: an online discrete-choice experiment survey
C Mansfield, MV Sikirica, A Pugh, CM Poulos… - Diabetes Therapy, 2017 - Springer
Introduction Understanding patient preferences for attributes of type 2 diabetes mellitus
(T2DM) medications may help explain how the attributes differentially affect patient …
(T2DM) medications may help explain how the attributes differentially affect patient …
Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment
C Morillas, R Feliciano, PF Catalina… - Patient preference …, 2015 - Taylor & Francis
Objective To assess Spanish and Portuguese patients' and physicians' preferences
regarding type 2 diabetes mellitus (T2DM) treatments and the monthly willingness to pay …
regarding type 2 diabetes mellitus (T2DM) treatments and the monthly willingness to pay …
Patient preferences for noninsulin diabetes medications: a systematic review
TS Purnell, S Joy, E Little, JFP Bridges… - Diabetes …, 2014 - Am Diabetes Assoc
OBJECTIVE An evidence-based synthesis of patient preferences for management of
hyperglycemia is needed. Our objective was to systematically review patient preferences for …
hyperglycemia is needed. Our objective was to systematically review patient preferences for …
Patient preferences for diabetes treatment among people with type 2 diabetes mellitus in China: a discrete choice experiment
Y Huang, Q Huang, A Xu, M Lu, X Xi - Frontiers in Public Health, 2022 - frontiersin.org
Introduction Preferences for diabetes treatment-related attributes may be significant in
diabetes management. However, there is a lack of evidence on patient preferences for …
diabetes management. However, there is a lack of evidence on patient preferences for …
Patient preferences for pharmacological diabetes treatment among people with diabetes in Spain: a discrete choice experiment
F Gómez-Peralta, M Mareque, Á Muñoz, M Maderuelo… - Diabetes Therapy, 2022 - Springer
Introduction The aim of the project was to describe the preferences related to the medication
attributes of people with diabetes mellitus (DM) treated in Spain. Methods The project was …
attributes of people with diabetes mellitus (DM) treated in Spain. Methods The project was …
Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK
HL Gelhorn, SM Stringer, A Brooks… - Diabetes, Obesity …, 2013 - Wiley Online Library
Aim To examine preferences for oral medication attributes among participants with early and
advanced type 2 diabetes mellitus (T2DM) in the UK using a discrete choice experiment …
advanced type 2 diabetes mellitus (T2DM) in the UK using a discrete choice experiment …
Patient preferences for medications in managing type 2 diabetes mellitus: a discrete choice experiment
Objectives To quantify patients' maximum acceptable risk (MAR) of urinary and genital tract
infections (UGTI) in exchange for benefits associated with treatments for managing type 2 …
infections (UGTI) in exchange for benefits associated with treatments for managing type 2 …
相关搜索
- diabetes mellitus patient preferences
- choice experiment patient preferences
- diabetes mellitus choice experiment
- diabetes mellitus medication attributes
- weight gain patient preferences
- germany and spain patient preferences
- diabetes treatment patient preferences
- diabetes medications patient preferences
- diabetes in spain patient preferences
- people with diabetes patient preferences
- diabetes mellitus antihyperglycemic medications
- sweden and germany patient preferences